ArticleCase reports in medicine2026

Remarkable Response to Immunotherapy and VEGFR Inhibitor in Xp11 Translocation Renal Cell Carcinoma in a 17-Year-Old Adolescent.

Piyarat Limpawittayakul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.